PQE Group: 100+M€ in Revenues

Contributed by: Business Wire

Logo

Images

Gilda D’Incerti, PQE Group CEO & Founder (Photo: Business Wire)

Business Wire embedded0

Tags

Professional Services

Health

Medical Devices

Clinical Trials

Consulting

Pharmaceutical

Biotechnology

Fiscal Year 2023

More Like This

PQE Group Reports Solid Year-End Results, Strengthens Position through Innovation in Pharmaceuticals and Medical Devices

PQE Group Among the 79 Excellence Awardees of the 6th Edition of Deloitte Private's "Best Managed Companies" Award

2024 Pharma Quality Europe Sustainability Report

PQE Group Announces Release of 2024 Sustainability Report

Danilo Neri - Partner & Vice President Executive at PQE Group (Photo: PQE Group)

PQE Group Launches AI and Data Analytics Division: Innovation in the Service of Life Science

Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities

News Aktuell associated0

THE QUALITY GROUP GROWS H1 REVENUE BY MORE THAN 40% TO OVER EUR850 MILLION

PRODUCTLIFE GROUP ACQUIRES STRATEGIQUAL, REINFORCING ITS POSITION AS QUALITY & REGULATORY LEADER ON THE FRENCH MARKET